For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Facet Biotech Corporation

Calculating rank

USPTO Granted Patents = 17

% Expired Patents = 41.2

EPO Patents = 4

Forward Citations = 125

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Vinay Bhaskar (8 out of 39 patents)

Vanitha Ramakrishnan (6 out of 20 patents)

David Powers (6 out of 29 patents)

4. Debbie Law (6 out of 10 patents)

5. Naoya Tsurushita (4 out of 51 patents)

6. Daniel E Afar (4 out of 36 patents)

7. Richard Murray (4 out of 6 patents)

8. Agustin De La Calle (3 out of 5 patents)

9. Paul Robert Hinton (3 out of 21 patents)

10. Ingrid W Caras (3 out of 16 patents)

11. Robert B Dubridge (2 out of 49 patents)

12. Paul J Maddon (2 out of 48 patents)

13. Supriya Gupta (2 out of 15 patents)

14. William C Olson (2 out of 88 patents)

15. Elizabet Kaisheva (2 out of 4 patents)

17 patents: Sort by Forward Citations

1. 8298530 - Stable lyophilized pharmaceutical formulation of IgG antibodies (2012-10-30),

2. 7914789 - HEMCM42 antibodies (2011-03-29),

3. 7879987 - Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis (2011-02-01),

4. 7851600 - Anti-CCR5 antibody (2010-12-14),

5. 7842293 - Compositions and methods using anti-CS1 antibodies to treat multiple myeloma (2010-11-30),

6. 7824678 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-11-02),

7. 7807163 - Antibodies against GPR64 and uses thereof (2010-10-05),

8. 7785816 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-08-31),

9. 7776585 - Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis (2010-08-17),

10. 7732570 - Alteration of Fc-fusion protein serum half-lives by mutagenesis (2010-06-08),

11. 7732195 - Tethered vectors for cell surface immunoglobulin display (2010-06-08),

12. 7709610 - Therapeutic use of anti-CS1 antibodies (2010-05-04),

13. 7674883 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-03-09),

14. 7666419 - Anti-CCR5 antibody (2010-02-23),

15. 7662384 - Use of anti-α5β1 antibodies to inhibit cancer cell proliferation (2010-02-16),

Company Overview

Facet Biotech Corporation, based in Redwood City, California, is a biopharmaceutical company focused on the development of innovative therapies for serious diseases. The organization specializes in advancing biologics and small molecules, with a strong emphasis on oncology and autoimmune disorders. Through its research initiatives, Facet aims to address unmet medical needs by leveraging cutting-edge technology and scientific expertise, fostering collaborations to enhance drug discovery and development processes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

17 Patents

#103 in Redwood City, CA

#4,521 in California

#18,913 in US

#35,974 in the World

Redwood City, CA, United States of America

Facet Biotech Corporation

Forward Citations = 125

31 inventors:

Vinay Bhaskar (8 out of 39 patents)

Vanitha Ramakrishnan (6 out of 20 patents)

David Powers (6 out of 29 patents)

4. Debbie Law (6 out of 10 patents)

5. Naoya Tsurushita (4 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Facet Biotech Corporation. Retrieved from https://idiyas.com/company/facet-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…